Abstract:Membrane permeability plays an important role in oral drug absorption. Caco-2 and Madin-Darby Canine Kidney (MDCK) cell culture systems have been widely used for assessing intestinal permeability. Since most drugs are absorbed passively, Parallel Artificial Membrane Permeability Assay (PAMPA) has gained popularity as a low-cost and high-throughput method in early drug discovery when compared to high-cost, labor intensive cell-based assays. At the National Center for Advancing Translational Sciences (NCATS), PAMPA pH 5 is employed as one of the Tier I absorption, distribution, metabolism, and elimination (ADME) assays. In this study, we have developed a quantitative structure activity relationship (QSAR) model using our ∼6500 compound PAMPA pH 5 permeability dataset. Along with ensemble decision tree-based methods such as Random Forest and eXtreme Gradient Boosting, we employed deep neural network and a graph convolutional neural network to model PAMPA pH 5 permeability. The classification models trained on a balanced training set provided accuracies ranging from 71% to 78% on the external set. Of the four classifiers, the graph convolutional neural network that directly operates on molecular graphs offered the best classification performance. Additionally, an ∼85% correlation was obtained between PAMPA pH 5 permeability and in vivo oral bioavailability in mice and rats. These results suggest that data from this assay (experimental or predicted) can be used to rank-order compounds for preclinical in vivo testing with a high degree of confidence, reducing cost and attrition as well as accelerating the drug discovery process. Additionally, experimental data for 486 compounds (PubChem AID: 1645871) and the best models have been made publicly available (https://opendata.ncats.nih.gov/adme/).

Advances in Parallel Artificial Membrane Permeability Assay and Its Applications

Optimization of a Parallel Artificial Membrane Permeability Assay for the Fast and Simultaneous Prediction of Human Intestinal Absorption and Plasma Protein Binding of Drug Candidates: Application to Dibenz[b,f]azepine-5-Carboxamide Derivatives

Using in vitro ADME data for lead compound selection: An emphasis on PAMPA pH 5 permeability and oral bioavailability

New biomimetic barrier PermeapadTM for efficient investigation of passive permeability of drugs

A Novel Design of Artificial Membrane for Improving the PAMPA Model

Comparison of in vitro membrane permeabilities of diverse environmental chemicals with in silico predictions

Highly predictive and interpretable models for PAMPA permeability

A new PAMPA model proposed on the basis of a synthetic phospholipid membrane.

Rapid Screening of Brain-Penetrable Antioxidants from Natural Products by Blood-Brain Barrier Specific Permeability Assay Combined with DPPH Recognition.

Application Progress of Immobilized Biomembrane in the Discovery of Active Compounds of Natural Products.

Polymer membrane and cell models for drug discovery.

Development of In-Vitro Evaluation Methods to Access Membrane Permeability of Drugs

High-Throughput SFC-MS/MS Method to Measure EPSA and Predict Human Permeability

Advances in Computational Approaches for Estimating Passive Permeability in Drug Discovery

Recent developments in the application of immobilized artificial membrane (IAM) chromatography to drug discovery

Improving the Accuracy of Permeability Data to Gain Predictive Power: Assessing Sources of Variability in Assays Using Cell Monolayers

Applications of Biomembrane in Pharmaceutical Research

High throughput screening of physicochemical properties and in vitro ADME profiling in drug discovery

Permeation Prediction of M100240 Using the Parallel Artificial Membrane Permeability Assay.

Advances in immobilized artificial membrane (IAM) chromatography for novel drug discovery

Characterization of Drug Permeability in Caco-2 Monolayers by Mass Spectrometry on A Membrane-Based Microfluidic Device